The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis Patients

Condition:   Hemodialysis Patients Intervention:   Drug: Evogliptin 5mg Sponsor:   Dong-A ST Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials